AbbVie (ABBV): New Sell Recommendation for This Healthcare Giant

BMO Capital analyst Alex Arfaei maintained a Sell rating on AbbVie (NYSE: ABBV) today and set a price target of $78. The company’s shares opened today at $92.39.

According to, Arfaei is a 4-star analyst with an average return of 7.7% and a 71.9% success rate. Arfaei covers the Healthcare sector, focusing on stocks such as Merck & Company, Eli Lilly & Co, and Bristol Myers.

The word on The Street in general, suggests a Hold analyst consensus rating for AbbVie with a $96.60 average price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $125.86 and a one-year low of $83.19. Currently, AbbVie has an average volume of 6.01M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.